Head and Neck Cancers, Laryngeal Neoplasms, Larynx Cancer
Conditions
Brief summary
To determine if high resolution MRI can detect early invasion of cartilage by laryngeal carcinoma, and to determine if high resolution MRI may be superior to conventional MRI imaging or CT imaging to detect cartilage invasion.
Detailed description
The purpose of this study is to use a new MRI imaging coil developed for enhancing structures made of cartilage to determine if the device can produce improved images of the human larynx. In addition, if enhanced images can be obtained, a further purpose will be to determine if, in patients with laryngeal cancer, whether or not early invasion of cartilage can be detected. Patients with laryngeal cancer will be asked to undergone an MRI scan using this new image-enhancing coil to see if cartilage invasion can be detected. Patients will be followed during and after treatment to determine their ultimate response to treatment. No additional MRI scans for the purposes of this protocol will be performed other than the initial pretreatment scan. We hope to determine if this new MRI imaging device can detect early cancer invasion of the laryngeal cartilages in patients with laryngeal cancer. Since this modality has never been attempted before on the human larynx, we are simply looking for the presence or absence of cartilage destruction. Both conventional CT and conventional MRI are poor at recongnizing this finding. High resolution MRI may allow the detection of this finding or it may not - detection of this finding is the endpoint.
Interventions
PROCEDUREMRI scan
Standard of Care
Sponsors
Stanford University
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients with benign or malignant neoplasm of the larynx. * Patients who have undergone prior surgery, radiation therapy, or chemotherapy for cancer of the laryngopharynx will be eligible to participate. * Patients 18 years of age and older at time of evaluation, male and female, all ethnicities. * Ability to understand and the willingness to sign a written informed consent document.
Exclusion criteria
* Pregnancy * Claustrophobia. * Anatomic parameters which preclude scanning, such as limited range of neck motion, or inability to remain flat for at least 15 minutes. * Patients with implanted devices (eg, defibrillator, pacemaker) that are a known contraindication to magnetic resonance imaging. * Allergy to gadolinium contrast.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Tumor stage as determined by HRMRI. | 24 to 48 hours | Radiologic tumor stage |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Estimate the precision of HRMRI in discriminating between edema and tumor in patients with prior radiotherapy or chemotherapy. | 4 to 6 weeks | Comparison of true tumor dimension as predicted by HRMRI versus true tumor size as shown on final histopathology |
| Tumor stage as determined by histopathology in excised larynges. | 4 to 6 weeks | Pathological tumor stage |
Countries
United States
Outcome results
None listed